NASDAQ:PDSB
PDS Biotechnology Corporation
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.pdsbiotech.comipo date
Sep 30, 2015
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer. The compan...Show More
Earnings
Earnings Release in 16 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus